XRP in Corporate Treasuries: Revolution or Overhyped Bet?
Corporate treasuries are flirting with crypto—again. This time, it’s XRP in the spotlight, promising faster settlements and lower fees than legacy systems. But is it ready for prime time?
Ripple’s darling asset has been on a rollercoaster: regulatory wins one day, SEC lawsuits the next. Meanwhile, CFOs still treat crypto like a Vegas side-hustle. The tech? Solid. The adoption curve? Steeper than a Wall Street banker’s arrogance.
Here’s the kicker: if XRP cracks the treasury game, it could bypass SWIFT’s 1970s infrastructure entirely. That’s a big ’if’—most treasurers still think DeFi is a typo.
Companies Turn to XRP for Treasury Strategy
Yesterday, VivoPower International PLC (Nasdaq: VVPR), a publicly listed energy company announced it had raised $121 million through a private share sale to support its new XRP treasury strategy.
The share sale was led by Saudi Prince Abdulaziz bin Turki Abdulaziz Al Saud, who contributed $100 million. The company sold 20 million shares at $6.05 each, which was slightly higher than its last trading price.
Meanwhile, Hyperscale Data Inc. has also joined the trend. In a tweet on May 28, Hyperscale announced that its subsidiary, Ault Capital Group (ACG), is planning to acquire up to $10 million worth of XRP by the end of the year. The company said it’s doing this to expand into blockchain-based services, including decentralized finance (DeFi), tokenized assets, and real-time payments.
According to the announcement, The XRP will be listed on Hyperscale’s balance sheet at fair value, and price changes will be recorded through operating expenses. Earlier this month, another compnay, Wellgistics Health secured a $50 million equity line of credit from New York-based LDA Capital to purchase XRP as treasury.
According to the Florida-based pharmaceutical distributor, it also planned to use the cryptocurrency as a payment tool. Wellgistic said XRP transfers cost less than a cent and settle in just 3 to 5 seconds, compared to traditional wire and ACH payments that take days and charge higher fees.
“We believe that there are certain advantages to integrating XRP and its related infrastructure into its healthcare ecosystem,” Wellgistics said in a statement.
In addition, on the day of XRP Conference in Las Vegas Webus International Ltd. announced plans to buy up to $300 million worth of Ripple’s XRP to establish a strategic reserve. They also aim to develop infrastructure and accelerate their global expansion initiatives.
XRP ETF Still Under Review
At the same time, the talk of XRP ETF products getting approval is hitting up the market. According to a previous report, the U.S. Securities and Exchange Commission (SEC) has started reviewing WisdomTree application for an XRP Trust.
If approved, this WOULD allow the institution a convenient way to invest in XRP without owning it directly. Instead, they could buy shares on the Cboe BZX Exchange that follow the price of XRP. The SEC now has 240 days to decide whether to approve or reject the product, meaning a decision could come by late January 2026.
Several other companies like Bitwise, Canary Capital, and 21Shares have also proposed similar XRP products. If XRP ETF is approved, we may see more company diversifying their treasury by adding XRP too.
Also Read: Can xrp price Mirror Apple’s 50000% Surge Since 2005?
